• Profile
Close

Development and validation of a new scoring system to predict survival in patients with myotonic dystrophy type 1

JAMA Neurology Feb 11, 2018

Wahbi K, et al. - The purpose of this research was to formulate and validate a prognostic score in order to speculate the 10-year survival in patients with myotonic dystrophy type 1 (DM1). The DM1 prognostic score was developed and validated internally and externally based on a set of common patient characteristics: Age, diabetes, need for support when walking, heart rate, systolic blood pressure, first-degree atrioventricular, bundle-branch block, and vital capacity. Researchers drew the conclusion that DM1 prognostic score was linked with the long-term survival.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay